Robuta

https://www.tga.gov.au/resources/guidance/ctd-module-1-administrative-information-assessed-listed-medicines CTD Module 1: Administrative information for assessed listed medicines | Therapeutic Goods... Apr 10, 2026 - Guidance about the administrative information to support assessed listed medicine applications. assessed listed medicinesadministrative informationctdmodule1 https://www.tga.gov.au/products/medicines/listed-medicines Listed medicines | Therapeutic Goods Administration (TGA) Lower risk medicines containing pre-approved, low-risk ingredients and that make limited claims can be listed on the Australian Register of Therapeutic Goods.... listed medicinestherapeuticgoodsadministrationtga https://www.tga.gov.au/products/medicines/listed-medicines/application-and-market-authorisation/listed-medicines-training Listed medicines training | Therapeutic Goods Administration (TGA) Oct 18, 2025 - Access learning modules to help you understand how to use the Evidence Guidelines. listed medicinestrainingtherapeuticgoodsadministration https://www.tga.gov.au/products/medicines/registered-complementary-medicines/application-and-market-authorisation/other-resources-sponsors-listed-medicines-and-registered-complementary-medicines Other resources for sponsors of listed medicines and registered complementary medicines |... Oct 18, 2025 - Resources for sponsors of listed medicines and registered complementary medicines other resourcesfor sponsorslisted medicinesregisteredcomplementary https://www.miragenews.com/efficacy-of-listed-medicines-for-exercise-1668968/ Efficacy Of Listed Medicines For Exercise Performance | Mirage News The TGA initiated targeted compliance reviews of select listed medicines containing Magnesium to verify whether sponsors had appropriate evidence to efficacy oflisted medicinesfor exerciseperformancemirage https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-containing-mollusc-derived-ingredients-requiring-warning-statements Listed medicines containing mollusc-derived ingredients requiring warning statements | Therapeutic... Oct 27, 2025 - In 2024, we initiated targeted compliance reviews of selected listed medicines that required warning statements on their labels as they contained... listed medicinescontainingmolluscderivedingredients https://www.tga.gov.au/news/news-articles/listed-medicines-requiring-warning-statement Listed medicines requiring a warning statement | Therapeutic Goods Administration (TGA) Nov 4, 2025 - We will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement listed medicinesa warningrequiringstatementtherapeutic https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines Compliance and education for listed medicines | Therapeutic Goods Administration (TGA) May 7, 2026 - Find out about our compliance review activities for listed medicines and how to avoid common compliance issues. compliance and educationlisted medicinestherapeuticgoodsadministration https://www.tga.gov.au/products/medicines/assessed-listed-medicines/monitoring-and-compliance Monitoring and compliance for assessed listed medicines | Therapeutic Goods Administration (TGA) Oct 29, 2025 - Understand your ongoing post-market responsibilities for assessed listed medicines. monitoring and complianceassessed listed medicines https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-requiring-pregnancy-warning-statement Listed medicines requiring a pregnancy warning statement | Therapeutic Goods Administration (TGA) Oct 31, 2025 - We will be initiating targeted compliance reviews of selected listed medicines that require warning statements related to use during pregnancy. listed medicineswarning statementrequiringpregnancy https://www.tga.gov.au/resources/resources/user-guide/evaluation-substances-use-listed-medicines-and-assessed-listed-medicines-user-guide Evaluation of substances for use in listed medicines and assessed listed medicines: user guide |... Oct 10, 2025 - A user guide for applicants using the TGA Business services (TBS) portal to complete an online application form for a new substance application. for use https://www.tga.gov.au/resources/guidance/sampling-and-testing-listed-and-complementary-medicines Sampling and testing for listed and complementary medicines | Therapeutic Goods Administration (TGA) Jan 5, 2026 - Guidance for interpreting the Pharmaceutical Inspection Co-operation Scheme (PIC/S) guide to good manufacturing practice (GMP) for medicinal products. complementary medicinessamplingtestinglisted https://www.tga.gov.au/products/medicines/listed-medicines/monitoring-and-compliance/compliance-and-education-listed-medicines/listed-medicines-are-required-be-tested-presence-aristolochic-acids Listed medicines that are required to be tested for the presence of Aristolochic acids |... Apr 10, 2026 - Updated information on requirement to test for presence of aristolochic acids in certain listed medicines https://www.tga.gov.au/resources/guidance/demonstrating-quality-listed-probiotic-medicines Demonstrating the quality of listed probiotic medicines | Therapeutic Goods Administration (TGA) Jan 5, 2026 - Guidance for sponsors and manufacturers to meet the technical, scientific and regulatory requirements to ensure the quality of probiotic medicine acceptable... the qualitydemonstratinglisted